Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical outcome and influencing factors of differentiated thyroid cancer with biochemical incomplete response.

Future oncology (London, England) - 1 Sept 2025

Wang Congcong, Qin Guohua, Wang Shuhui, Li Yutian, Lu Yaqi, Shen Xia, Sun Wei, Li Jiao, Han Na, Lu Chenghui, Wang Guoqiang, Zhang Yingying, Wang ZengHua, Si Zengmei, Li Fengqi, Wang Xufu, Lin Yansong, Liu Xinfeng

Abstract excerpt

PURPOSE: The aim of our study was to investigate the clinical outcomes and predictive factors in patients with biochemical incomplete response (BIR) after initial radioiodine therapy (RAI). MATERIALS & METHODS: This retrospective study enrolled 198 patients with BIR from two institutions and stratified them into a training cohort (Qingdao cohort, n = 144) and an external validation cohort (Beijing cohort,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Iodine Radioisotopes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Nomograms

Share to Proto-Oncogene Proteins B-raf

Share to ROC Curve

Share to Thyroglobulin

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 40832960
DOI: 10.1080/14796694.2025.2548161
PMCID: PMC12439549

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical outcome and influencing factors of differentiated thyroid cancer with biochemical incomplete response.PMID 40832960Read ↗

A predictive nomogram for progression-free survival in radioiodine-refractory papillary thyroid carcinoma after reoperation: a longitudinal study in Vietnam.Semantic proximity Read ↗

Disease Progression in Papillary Thyroid Cancer with Biochemical Incomplete Response to Initial Therapy.Semantic proximity Read ↗

Association of BRAF Mutation with Treatment Response and Prognostic Factors in Papillary Thyroid Carcinoma: A Retrospective Cohort StudySemantic proximity Read ↗

Efficacy of Radioiodine in Non-Distant Metastatic Papillary Thyroid Cancer with TERT-p Mutation at Initial DiagnosisSemantic proximity Read ↗

Predictive factors of outcome in poorly differentiated thyroid carcinomas.Semantic proximity Read ↗

Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer.Semantic proximity Read ↗

Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective studySemantic proximity Read ↗

Clinical Outcome and Prognosis of Differentiated Thyroid Carcinoma with Distant MetastasisSemantic proximity Read ↗

The BRAFV600E Mutation Enhances Age-Based Prognostic Stratification in Radioiodine-Treated Papillary Thyroid Cancer: A Retrospective Cohort Study.Semantic proximity Read ↗

Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations.Semantic proximity Read ↗

Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer.Semantic proximity Read ↗

Risk of second primary malignancy after radioiodine for thyroid carcinoma: a SEER-based studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.